HC Wainwright reaffirmed their buy rating on shares of Medical Transcription Billing (NASDAQ:MTBC) in a research report released on Thursday. HC Wainwright currently has a $5.00 price objective on the technology company’s stock.
“Financials; Expansion Opportunities Abound; Reit Buy Stock Data 03/07/2018 Price $3.53 Exchange NASDAQ Price Target $5.00 52-Week High $5.44 52-Week Low $0.29 Enterprise Value (M) $65 Market Cap (M) $41 Shares Outstanding (M) 11.5 3 Month Avg Volume 443,753 Short Interest (M) 1.00 Balance Sheet Metrics Cash (M) $4.4 Total Debt (M) $0.3 Total Cash/Share $0.38 General: EV includes 1.116M preferred shares at $25.89/shr. 3/7/18 for $28.9M in capitalization.”,” HC Wainwright’s analyst wrote.
A number of other research analysts also recently weighed in on the company. Chardan Capital raised their price target on Medical Transcription Billing from $2.25 to $2.75 and gave the company a buy rating in a research note on Tuesday, November 14th. Zacks Investment Research downgraded Medical Transcription Billing from a buy rating to a hold rating in a research note on Saturday, January 6th. Finally, ValuEngine downgraded Medical Transcription Billing from a hold rating to a sell rating in a research note on Monday, December 4th.
Medical Transcription Billing (NASDAQ:MTBC) last posted its quarterly earnings results on Wednesday, March 7th. The technology company reported $0.04 earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.01) by $0.05. The firm had revenue of $8.29 million during the quarter, compared to the consensus estimate of $8.30 million. Medical Transcription Billing had a negative return on equity of 10.97% and a negative net margin of 17.50%.
TRADEMARK VIOLATION WARNING: “Medical Transcription Billing’s (MTBC) “Buy” Rating Reaffirmed at HC Wainwright” was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3257696/medical-transcription-billings-mtbc-buy-rating-reaffirmed-at-hc-wainwright.html.
About Medical Transcription Billing
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.
Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.